GB1531231A - Process for the production of cyanoguanidine derivatives - Google Patents

Process for the production of cyanoguanidine derivatives

Info

Publication number
GB1531231A
GB1531231A GB38258/74A GB3825874A GB1531231A GB 1531231 A GB1531231 A GB 1531231A GB 38258/74 A GB38258/74 A GB 38258/74A GB 3825874 A GB3825874 A GB 3825874A GB 1531231 A GB1531231 A GB 1531231A
Authority
GB
United Kingdom
Prior art keywords
production
cyanoguanidine derivatives
cyanoguanidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38258/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to GB38258/74A priority Critical patent/GB1531231A/en
Priority to IE1798/75A priority patent/IE41651B1/en
Priority to US05/606,268 priority patent/US4049671A/en
Priority to CA233,789A priority patent/CA1064037A/en
Priority to BE159394A priority patent/BE832664A/xx
Priority to CH1105075A priority patent/CH608233A5/xx
Priority to JP50106459A priority patent/JPS5946222B2/ja
Priority to NL7510334A priority patent/NL7510334A/xx
Publication of GB1531231A publication Critical patent/GB1531231A/en
Priority to JP59099672A priority patent/JPS6023370A/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB38258/74A 1974-09-02 1974-09-02 Process for the production of cyanoguanidine derivatives Expired GB1531231A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB38258/74A GB1531231A (en) 1974-09-02 1974-09-02 Process for the production of cyanoguanidine derivatives
IE1798/75A IE41651B1 (en) 1974-09-02 1975-08-12 Process for the production of cyanoguandine derivatives
US05/606,268 US4049671A (en) 1974-09-02 1975-08-20 Process for preparing N-cyanoguanidines
CA233,789A CA1064037A (en) 1974-09-02 1975-08-20 Process for preparing substituted granidines
BE159394A BE832664A (fr) 1974-09-02 1975-08-22 Procede perfectionne de preparation de cyanoghanidines et produits obtenus
CH1105075A CH608233A5 (en, 2012) 1974-09-02 1975-08-26
JP50106459A JPS5946222B2 (ja) 1974-09-02 1975-09-01 グアニジン化合物の製法
NL7510334A NL7510334A (nl) 1974-09-02 1975-09-02 Werkwijze voor het bereiden van guanidineverbin- dingen.
JP59099672A JPS6023370A (ja) 1974-09-02 1984-05-15 グアニジン化合物の製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38258/74A GB1531231A (en) 1974-09-02 1974-09-02 Process for the production of cyanoguanidine derivatives

Publications (1)

Publication Number Publication Date
GB1531231A true GB1531231A (en) 1978-11-08

Family

ID=10402299

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38258/74A Expired GB1531231A (en) 1974-09-02 1974-09-02 Process for the production of cyanoguanidine derivatives

Country Status (8)

Country Link
US (1) US4049671A (en, 2012)
JP (2) JPS5946222B2 (en, 2012)
BE (1) BE832664A (en, 2012)
CA (1) CA1064037A (en, 2012)
CH (1) CH608233A5 (en, 2012)
GB (1) GB1531231A (en, 2012)
IE (1) IE41651B1 (en, 2012)
NL (1) NL7510334A (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242350A (en) 1978-05-24 1980-12-30 Imperial Chemical Industries Limited Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109003A (en) * 1974-03-12 1978-08-22 Smith Kline & French Laboratories Limited Pharmacologically active compounds
GB1496787A (en) * 1974-03-12 1978-01-05 Smith Kline French Lab Heteroalkylthioalkyl amidine derivatives
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
NZ184893A (en) * 1976-09-21 1980-11-28 Smith Kline French Lab Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it
NO781300L (no) 1977-04-20 1978-10-23 Ici Ltd Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ187376A (en) * 1977-06-03 1981-05-29 Bristol Myers Co N-cyano-n-(2-(4-methyl-5-imidazolyl)methylthio)ethyl)-n-alkynyl guanidines intermediates pharmaceutical compositions
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
NO784350L (no) * 1977-12-30 1979-07-03 Crc Ricerca Chim Fremgangsmaate til alkylering av 4(5)-merkaptometyl-imidazoler med aziridinderivater
YU40332B (en) * 1978-04-26 1985-12-31 Lek Tovarna Farmacevtskih Process for preparing n-cyano-n'-methyl-n''-((2-((4-methyl-5-imidazolyl)-methylthio)ethyl)-guanidine
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
US4276421A (en) * 1978-11-18 1981-06-30 Societe De Recherches Et De Syntheses Organiques S.A. Cyano-guanidine geometrical isomers
DE3069889D1 (en) 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
JPH0192664A (ja) * 1987-10-03 1989-04-11 Ngk Insulators Ltd 線路用検電装置
JPH01123159A (ja) * 1987-11-06 1989-05-16 Ngk Insulators Ltd 線路用検電装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242350A (en) 1978-05-24 1980-12-30 Imperial Chemical Industries Limited Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1064037A (en) 1979-10-09
US4049671A (en) 1977-09-20
NL7510334A (nl) 1976-03-04
CH608233A5 (en, 2012) 1978-12-29
JPS5946222B2 (ja) 1984-11-10
BE832664A (fr) 1976-02-23
JPS5154562A (en, 2012) 1976-05-13
IE41651L (en) 1976-03-02
JPS6140668B2 (en, 2012) 1986-09-10
IE41651B1 (en) 1980-02-27
JPS6023370A (ja) 1985-02-05

Similar Documents

Publication Publication Date Title
HU174077B (hu) Sposob poluchenija proizvodnykh dekapeptidamidakh
GB1520798A (en) Process for the production of 2 - aryl - 2h - benzotriazoles
HU173052B (hu) Sposob poluchenija proizvodnykh tienil-karbamida
GB1531231A (en) Process for the production of cyanoguanidine derivatives
HU172039B (hu) Sposob poluchenija proizvodnykh 2-fenil-indola
CA1030556A (en) Process for the production of hydroxy-pivaldehyde
HU172103B (hu) Sposob poluchenija proizvodnykh 2-skobka-zamehhennykh-skobka zakryta-3-cianamino-3-skobka-zamehhennykh amino-skobka zakryta-propionitrilov
HU172906B (hu) Sposob poluchenija proizvodnykh alkil-amino-glikopiranozida
IL48639A (en) Process for the production of carbonylaldiminomethanephosphosphonates
YU40266B (en) Process for producing thienothiazepine derivatives
HU174005B (hu) Sposob poluchenija proizvodnykh analogov prostaglandina
HU171512B (hu) Sposob polucsenija proizvodnykh nikotinamid-adenin-dinukleotidov
GB1486146A (en) Process for producing l-cysteine or its derivatives
HU173609B (hu) Sposob poluchenija novykh proizvodnykh salicilanilida
HU171325B (hu) Sposob poluchenija 2-amino-2-imidazolina
YU165781A (en) Process for producing penzopyran derivatives
HU171206B (hu) Sposob poluchenija novykh proizvodnykh fenil-piridil-allilamina
GB1520681A (en) Process for the production of phoroglucinol
ZA757523B (en) Process for the production of jodophors
EG13030A (en) Process for the production of n,n diallyldichloroacetamide
YU326975A (en) Process for producing new dianhydro-hexyte derivatives
HU175915B (en) Process for producing monochromone derivatives
HU173656B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-skobka-beta-aminoetil-skobka zakryta-ergolina-i
IL47610A0 (en) Process for the manufacture of derivatives of norbornene
HU170782B (hu) Sposob poluchenija proizvodnykh l-aril-uracila

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee